OVERWEIGHT AND OBESE ADULTS
Clinical trials for OVERWEIGHT AND OBESE ADULTS explained in plain language.
Never miss a new study
Get alerted when new OVERWEIGHT AND OBESE ADULTS trials appear
Sign up with your email to follow new studies for OVERWEIGHT AND OBESE ADULTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Vitamin B3 trial aims to halt liver damage
Disease control Recruiting nowThis study is testing whether a form of vitamin B3 called nicotinamide can stop or even reverse liver scarring (fibrosis) in people with fatty liver disease. About 30 overweight or obese adults will take either nicotinamide or a placebo pill daily for one year. Researchers will u…
Matched conditions: OVERWEIGHT AND OBESE ADULTS
Phase: PHASE2 • Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
App aims to help shrink waistlines with virtual dietitian support
Disease control Recruiting nowThis study is testing a 6-month digital program designed to help adults with obesity lose weight and improve their health habits. About 93 participants will use an app with weekly readings, tasks, and regular video calls with a licensed dietitian. Researchers will track changes i…
Matched conditions: OVERWEIGHT AND OBESE ADULTS
Phase: NA • Sponsor: Eatit AB • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Can better sleep be the missing link for weight loss? new program tests the theory
Disease control Recruiting nowThis is a small, early-stage pilot study to see if a standard behavioral weight loss program works better when combined with strategies to improve sleep health. Researchers will enroll about 25 overweight adults who also have poor sleep habits to test if the combined approach is …
Matched conditions: OVERWEIGHT AND OBESE ADULTS
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
First test of new drug in healthy volunteers
Knowledge-focused Recruiting nowThis is the first study in humans for a new drug called SYNT-101. It aims to check the safety and how the body processes the drug in 64 healthy adults, including some who are overweight. Participants will receive either the drug or a placebo, and researchers will monitor for any …
Matched conditions: OVERWEIGHT AND OBESE ADULTS
Phase: PHASE1 • Sponsor: Syntis Bio • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC